Sjoerd J Finnema1,2, Christer Halldin3, Benny Bang-Andersen4, Christoffer Bundgaard4, Lars Farde3,5. 1. Department of Clinical Neuroscience, Center for Psychiatric Research, Karolinska Institutet, Karolinska University Hospital, Building R5:02, SE-17176, Stockholm, Sweden. sjoerd.finnema@ki.se. 2. Department of Diagnostic Radiology, Yale University, New Haven, CT, USA. sjoerd.finnema@ki.se. 3. Department of Clinical Neuroscience, Center for Psychiatric Research, Karolinska Institutet, Karolinska University Hospital, Building R5:02, SE-17176, Stockholm, Sweden. 4. H. Lundbeck A/S, Neuroscience Drug Discovery Denmark, Valby, Denmark. 5. AstraZeneca, Translational Science Center at Karolinska Institutet, Stockholm, Sweden.
Abstract
RATIONALE: A number of serotonin receptor positron emission tomography (PET) radioligands have been shown to be sensitive to changes in extracellular serotonin concentration, in a generalization of the well-known dopamine competition model. High doses of selective serotonin reuptake inhibitors (SSRIs) decrease serotonin receptor availability in monkey brain, consistent with increased serotonin concentrations. However, two recent studies on healthy human subjects, using a single, lower and clinically relevant SSRI dose, showed increased cortical serotonin receptor radioligand binding, suggesting potential decreases in serotonin concentration in projection regions when initiating treatment. OBJECTIVES: The cross-species differential SSRI effect may be partly explained by serotonin transporter (SERT) occupancy in monkey brain being higher than is clinically relevant. We here determine SERT occupancy after single doses of escitalopram or citalopram by conducting PET measurements with [(11)C]MADAM in monkeys. Relationships between dose, plasma concentration and SERT occupancy were estimated by one-site binding analyses. Binding affinity was expressed as dose (ID50) or plasma concentration (K i) where 50 % SERT occupancy was achieved. RESULTS: Estimated ID50 and K i values were 0.020 mg/kg and 9.6 nmol/L for escitalopram and 0.059 mg/kg and 9.7 nmol/L for citalopram, respectively. Obtained K i values are comparable to values reported in humans. CONCLUSIONS: Escitalopram or citalopram doses nearly saturated SERT in previous monkey studies which examined serotonin sensitivity of receptor radioligands. PET-measured cross-species differential effects of SSRI on cortical serotonin concentration may thus be related to SSRI dose. Future monkey studies using SSRI doses inducing clinically relevant SERT occupancy may further illuminate the delayed onset of SSRI therapeutic effects.
RATIONALE: A number of serotonin receptor positron emission tomography (PET) radioligands have been shown to be sensitive to changes in extracellular serotonin concentration, in a generalization of the well-known dopamine competition model. High doses of selective serotonin reuptake inhibitors (SSRIs) decrease serotonin receptor availability in monkey brain, consistent with increased serotonin concentrations. However, two recent studies on healthy human subjects, using a single, lower and clinically relevant SSRI dose, showed increased cortical serotonin receptor radioligand binding, suggesting potential decreases in serotonin concentration in projection regions when initiating treatment. OBJECTIVES: The cross-species differential SSRI effect may be partly explained by serotonin transporter (SERT) occupancy in monkey brain being higher than is clinically relevant. We here determine SERT occupancy after single doses of escitalopram or citalopram by conducting PET measurements with [(11)C]MADAM in monkeys. Relationships between dose, plasma concentration and SERT occupancy were estimated by one-site binding analyses. Binding affinity was expressed as dose (ID50) or plasma concentration (K i) where 50 % SERT occupancy was achieved. RESULTS: Estimated ID50 and K i values were 0.020 mg/kg and 9.6 nmol/L for escitalopram and 0.059 mg/kg and 9.7 nmol/L for citalopram, respectively. Obtained K i values are comparable to values reported in humans. CONCLUSIONS:Escitalopram or citalopram doses nearly saturated SERT in previous monkey studies which examined serotonin sensitivity of receptor radioligands. PET-measured cross-species differential effects of SSRI on cortical serotonin concentration may thus be related to SSRI dose. Future monkey studies using SSRI doses inducing clinically relevant SERT occupancy may further illuminate the delayed onset of SSRI therapeutic effects.
Authors: Johan Lundberg; Jacob Strøyer Christophersen; Kamilla Buchberg Petersen; Henrik Loft; Christer Halldin; Lars Farde Journal: Int J Neuropsychopharmacol Date: 2007-01-04 Impact factor: 5.176
Authors: Jeffrey H Meyer; Alan A Wilson; Sandra Sagrati; Doug Hussey; Anna Carella; William Z Potter; Nathalie Ginovart; Edgar P Spencer; Andy Cheok; Sylvain Houle Journal: Am J Psychiatry Date: 2004-05 Impact factor: 18.112
Authors: Jeffery Batis; Olivier Barret; David Alagille; Andrei O Koren; Jeffrey S Stehouwer; Kelly Cosgrove; Mark Goodman; John Seibyl; Gilles Tamagnan Journal: Nucl Med Biol Date: 2012-11 Impact factor: 2.408
Authors: S Selvaraj; F Turkheimer; L Rosso; P Faulkner; E Mouchlianitis; J P Roiser; P McGuire; P J Cowen; O Howes Journal: Mol Psychiatry Date: 2012-06-05 Impact factor: 15.992
Authors: H Yamanaka; C Yokoyama; H Mizuma; S Kurai; S J Finnema; C Halldin; H Doi; H Onoe Journal: Transl Psychiatry Date: 2014-01-07 Impact factor: 6.222
Authors: Ansel T Hillmer; David Matuskey; Yiyun Huang; Nabeel Nabulsi; Jim Ropchan; Richard E Carson; Stephanie S O'Malley; Kelly P Cosgrove Journal: J Nucl Med Date: 2020-01-31 Impact factor: 10.057